PreludeDx Partners with Learn Look Locate to Boost DCIS Patient…

Event summary

PreludeDx collaborated with Learn Look Locate to launch a patient education guide for DCIS treatment decisions.
The guide focuses on understanding recurrence risk and radiation therapy benefits using PreludeDx’s DCISionRT test.
Published on July 9, 2026, the resource aims to empower patients with personalized treatment discussions.
PreludeDx CEO Dan Forche emphasized making patient-friendly education more accessible.

The big picture

PreludeDx’s collaboration with Learn Look Locate underscores the growing emphasis on patient-centered care in oncology. By leveraging educational platforms, diagnostic companies are increasingly bridging gaps between clinical data and patient understanding, a trend likely to shape future treatment adherence and outcomes. The partnership also highlights the strategic importance of shared decision-making tools in managing early-stage breast cancer.

What we're watching

Adoption Pace: How quickly the educational resource will be integrated into clinical practice and patient decision-making.
Market Expansion: Whether this collaboration will expand PreludeDx’s reach beyond its current diagnostic offerings.
Regulatory Impact: The potential influence of such patient education initiatives on regulatory standards for DCIS treatment guidance.